minimal Common Oncology Data Elements (mCODE) Implementation Guide
1.16.0 - STU Release 2 (Ballot Version)

This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.16.0: STU 2 Ballot 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions

: cancer-related-medication-administration-doxorubicin-jenny-m - JSON Representation

Raw json | Download


{
  "resourceType" : "MedicationAdministration",
  "id" : "cancer-related-medication-administration-doxorubicin-jenny-m",
  "meta" : {
    "profile" : [
      "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: completed</p><p><b>category</b>: <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}\">Outpatient</span></p><p><b>medication</b>: <span title=\"Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 1790099}\">doxorubicin hydrochloride 20 MG per 10 ML Injection</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-jenny-m.html\">Generated Summary: Medical Record Number: MRN1234 (USUAL); Jenny M ; gender: female; birthDate: 1965-01-01</a></p><p><b>effective</b>: 2018-04-22</p><h3>Performers</h3><table class=\"grid\"><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a href=\"Practitioner-us-core-practitioner-nancy-oncology-nurse.html\">Generated Summary: id: 55667788; Nancy Nurse ; gender: female</a></td></tr></table><p><b>reasonReference</b>: <a href=\"Condition-primary-cancer-condition-jenny-m.html\">Generated Summary: <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/condition-clinical remission}\">Remission</span>; <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/condition-ver-status confirmed}\">Confirmed</span>; <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/condition-category problem-list-item}\">Problem List Item</span>; <span title=\"Codes: {http://snomed.info/sct 353431000119107}\">Primary malignant neoplasm of female left breast (disorder)</span>; onset: 2018-03-16</a></p><p><b>request</b>: <a href=\"MedicationRequest-cancer-related-medication-request-doxorubicin-jenny-m.html\">Generated Summary: status: active; intent: order; <span title=\"Codes: {http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}\">Outpatient</span>; <span title=\"Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 3639}\">DOXOrubicin</span>; authoredOn: 2018-04-12</a></p><p><b>note</b>: doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)</p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td><span title=\"Codes: {http://snomed.info/sct 47625008}\">Intravenous route (qualifier value)</span></td><td>105.96 mg</td></tr></table></div>"
  },
  "status" : "completed",
  "category" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/medicationrequest-category",
        "code" : "outpatient"
      }
    ]
  },
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "1790099",
        "display" : "doxorubicin hydrochloride 20 MG per 10 ML Injection"
      }
    ]
  },
  "subject" : {
    "reference" : "Patient/cancer-patient-jenny-m"
  },
  "effectiveDateTime" : "2018-04-22",
  "performer" : [
    {
      "actor" : {
        "reference" : "Practitioner/us-core-practitioner-nancy-oncology-nurse"
      }
    }
  ],
  "reasonReference" : [
    {
      "reference" : "Condition/primary-cancer-condition-jenny-m"
    }
  ],
  "request" : {
    "reference" : "MedicationRequest/cancer-related-medication-request-doxorubicin-jenny-m"
  },
  "note" : [
    {
      "authorReference" : {
        "reference" : "Practitioner/us-core-practitioner-nancy-oncology-nurse"
      },
      "time" : "2018-04-22",
      "text" : "doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."
    }
  ],
  "dosage" : {
    "route" : {
      "coding" : [
        {
          "system" : "http://snomed.info/sct",
          "code" : "47625008",
          "display" : "Intravenous route (qualifier value)"
        }
      ]
    },
    "dose" : {
      "value" : 105.96,
      "unit" : "mg",
      "system" : "http://unitsofmeasure.org",
      "code" : "mg"
    }
  }
}